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Passion will move men beyond themselves, beyond their shortcomings, beyond their failures.
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Abstract
Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. Although no cure
has yet been found for this disorder, it is possible to delay progression of its symptoms if therapeutic
intervention is provided at the earliest stage of the disease. However, the early diagnosis may be a
challenging task for physicians, since the subtle changes in brain tissues associated with the onset of
AD are difficult to detect by visual inspection of neuroimaging scans. Hence, in recent years, increasing
attention has been given to the development of computer-aided diagnosis (CAD) for AD, in order to
assist physicians in image analysis and interpretation. However, the majority of existing CAD systems
rely on the analysis of biomarkers at a single time-point, ignoring the progressive nature of the disorder.
In the present thesis, the value of incorporating information on cerebral metabolic patterns along time
for the automatic classification of AD was investigated. Baseline and multiple follow-up FDG-PET
scans of cognitively normal (CN), mild cognitive impairment (MCI) and AD subjects were used. Voxel-
based and multi-region analysis of cross-sectional and longitudinal FDG-PET images were performed.
In addition, different feature selection methods were tested, as well as several intensity normalization
approaches for FDG-PET images. The Support Vector Machine algorithm was used for CN vs AD, CN
vs MCI and MCI vs AD classification tasks. Although the longitudinal information did not seem to
have a great discriminative power, the combination of longitudinal and cross-sectional data enhanced
the classification results achievable using cross-sectional data alone. In fact, this combination led to
results that are in line with the current state-of-the-art, suggesting that longitudinal data may provide
valuable complementary information for the automatic diagnosis of AD.
Keywords
Alzheimer’s Disease, Computer-Aided Diagnosis, [18F] Fluorodeoxyglucose Positron Emission To-
mography, Longitudinal Analysis, Intensity Normalization, Feature Selection
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Resumo
A doenc¸a de Alzheimer (AD) e´ a forma mais comum de demeˆncia e, apesar de atualmente na˜o ter
cura, o seu diagno´stico precoce e´ essencial para agir de forma a retardar a progressa˜o dos sintomas.
Por esta raza˜o, o desenvolvimento de sistemas automa´ticos de diagno´stico usando imagens tridimen-
sionais do ce´rebro tem despertado um interesse crescente nos u´ltimos anos. No entanto, a maioria
dos sistemas propostos baseia-se na ana´lise das imagens apenas num instante temporal, ignorando a
natureza progressiva da doenc¸a. O presente estudo teve como principal objetivo investigar a relevaˆncia
da informac¸a˜o sobre o decl´ınio metabo´lico cerebral ao longo do tempo, para o diagno´stico automa´tico
da AD. Foram usados imagens de FDG-PET da baseline e de diversos follow-up de sujeitos cogniti-
vamente normais (CN), com de´fice cognitivo ligeiro (MCI) e pacientes com AD. De forma a extrair
as features destas imagens, foram utilizadas duas ana´lises distintas, nomeadamente uma abordagem
baseada em voxel-a-voxel e outra baseada em regio˜es de interesse. Ale´m disso, foram testados diferentes
me´todos para selecionar as features mais relevantes, bem como va´rias abordagens para normalizar a
intensidade das imagens de FDG-PET. O algoritmo Support Vector Machine foi usado para realizar
classificac¸o˜es bina´rias entre CN vs AD, CN vs MCI e MCI vs AD. Apesar da informac¸a˜o longitudinal
demonstrar na˜o ter um grande poder discriminativo por si so´, a combinac¸a˜o da informac¸a˜o de um
instante temporal com a variac¸a˜o ao longo do tempo levou a melhores desempenhos de classificac¸a˜o,
comparativamente a usar apenas os dados num instante temporal. Os resultados obtidos sugerem que
a informac¸a˜o longitudinal pode ser um complemento u´til para o diagno´stico automa´tico de AD.
Palavras Chave
Doenc¸a de Alzheimer, Diagno´stico Assistido por Computador, Tomografia por emissa˜o de positro˜es
com 18F-Fluorodeoxiglucose, Ana´lise Longitudinal, Normalizac¸a˜o da Intensidade, Selec¸a˜o de Features
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1
The aim of the present thesis is to investigate the value of longitudinal information for Computer-
Aided Diagnosis (CAD) of Alzheimer’s Disease (AD) using 3D brain images. CAD has become a highly
researched topic in the medical field in recent years, due to its high potential to improve diagnosis of
several types of abnormal conditions based on medical images. Since AD currently has no cure, an
early diagnosis is crucial in order to mitigate its symptoms. Hence, CAD schemes may be a valuable
tool to assist physicians in image analysis and interpretation, especially at earlier stages of the disease.
This chapter is organized as follows. A detailed description of AD’s pathogenesis, epidemiology and
diagnosis, with special emphasis on neuroimaging techniques, is presented in Section 1.1. The proposed
approach and original contributions are described in Section 1.2 and Section 1.3, respectively. Lastly,
in Section 1.4 the outline of the following chapters is provided.
1.1 Motivation - Alzheimer’s Disease
1.1.1 Overview
AD is a progressive neurodegenerative disorder and the most common cause of dementia in the
elderly [1]. Dementia refers to a state of progressive cognitive decline beyond the expected normal
consequence of aging. Since it’s a progressive disease, the symptoms gradually worsen over time and
dementia severity is usually classified according to the Clinical Dementia Rating (CDR) [2]. This
rating is based on the evaluation of 6 different domains: memory, orientation, judgment and problem
solving, community affairs, personal care, home and hobbies. CDR has 4 stages in which 0 means
no cognitive impairment; 0.5 connotes preclinical AD; 1, 2 and 3 means mild, moderate and severe
dementia, respectively. In addition to CDR, another tool is frequently used to evaluate the disease’s
progression, the Mini-Mental State Examination (MMSE) [3]. This exam aims to assess the overall
mental status and consists of 11 scored questions related with memory, attention, orientation, arith-
metic and language. The maximum score is 30 and a cutoff is suggested for classification purposes: a
score equal to or grater than 27 refers to a Cognitively Normal (CN) subject; a score between 21 and
26 indicates Mild Cognitive Impairment (MCI); a score between 11 and 20 suggests moderate cognitive
impairment; a score below 10 reveals a severe case of dementia.
Mild Cognitive Impairment
The MCI stage, also known as preclinical AD, is a transitional state between normal cognitive
decline due to aging and dementia. MCI is characterized by an evident memory impairment but with
overall preservation of the cognitive function, which can be difficult to diagnose accurately since it
may be mistaken for normal aging [4]. Nearly half of the patients diagnosed with MCI progress to
dementia within 3 or 4 years, and the majority of these patients declines to AD [5]. For this reason,
a distinction between MCI non-converts, i.e, MCI patients who remain stable over a certain period
of time, and converts, i.e., MCI patients who will progress to AD in the future has recently received
increasing attention in the research field (for example, [6] [7]). The early diagnosis of MCI converts
could have a significant impact on the course of dementia, since it would allow an early therapeutic
intervention and consequently a delay in the progression of the symptoms.
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Alzheimer’s Disease
The progression of AD is characterized by an overall memory loss and confusion with time and
place. The earliest stage of this condition begins with failure of short-term memory and a decline in
the ability to perform daily tasks. As the disease evolves, patients start to forget family members’
names and personal details such as their address and telephone number. As this stage progresses,
cognitive decline worsens and the patient loses the ability to remember recent events, which could lead
to behavior and personality changes. At the late stage, AD patients may forget how to perform basic
activities and they are completely dependent of help. All verbal abilities and basic motor skills such
as walking and swallowing are eventually lost, and the patient becomes unresponsive to the outside
world. At the final stage, AD patients are more vulnerable to infections such as pneumonia, which is
the most common cause of death [8]. Currently there is no cure for AD and it is an ultimately fatal
pathology.
1.1.2 Pathogenesis
AD is characterized by an overall brain atrophy with a significant loss of neurons. However, the
exact process underlying the onset of the disease is not completely understood yet. Despite some
diverging theories concerning the causes that lead to the onset of AD, there is a number of widely
accepted hallmarks. At the microscopic level, the principal hallmarks are the presence of β-amyloid
plaques (Aβ) and neurofibrillary tangles, along with neuronal degeneration [1].
Aβ is generated by cleavage of a larger protein called Amyloid-Precursor Protein (APP) which is
involved in cell membrane function. The Aβ is present throughout the body with large amounts con-
centrated in the brain. Under normal conditions, the Aβ present in the brain is degraded and cleared.
The central hypothesis for the cause of AD is the failure of this mechanism leading to the accumulation
of toxic concentrations of Aβ which aggregates into plaques thus causing neuronal degeneration and
consequently leading to dementia - the amyloid cascade hypothesis (Fig 1.1)[9]. The Apolipoprotein
E (ApoE) genotype was found to be the gene responsible for the clearance of Aβ [10], hence being
associated to a major risk of AD development.
Tangles are composed by tau proteins which have an important role in the nerve cell structure sta-
bilizing the microtubules. Tau proteins are essential to the normal function of the cells since they allow
the passage of nutrients. When the microtubule-associated tau protein in neurons becomes abnormally
hyperphosphorylated, twisted strands of tau proteins are formed which are accumulated into neurofib-
rillar tangles. Tangles cause disassembly of the microtubules, disrupting the structure and function
of the neuron and consequently the nutrients supply is not ensured, leading to abnormal neuronal
and synaptic functions. The presence of these neurofibrillar tangles is used to confirm Alzheimer’s
pathology in the autopsy ([12], [13]). The tau protein malfunction starts in the earlier stage of the
disease affecting the transentorhinal region, spreading in more advanced stages to the hippocampus
and amygdala and later to neocortical regions [14].
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Figure 1.1: The amyloid cascade hypothesis. APP generates Aβ which is accumulated into plaques, both
intra and extracellularly, leading to synaptic dysfunction and neuronal death. Source: Alzheimer’s Disease
[11].
The amyloid cascade hypothesis suggest that the abnormal function of the tau proteins is trigged
by the toxic accumulation of Aβ, although the interaction of these two mechanisms is not clearly
understood [15]. Together, Aβ plaques and tau tangles are currently the most accepted hallmarks of
AD, even though no consensus exists about which of them plays a more crucial role in the development
of AD symptoms.
The most affected brain areas in AD include the hippocampus, amygdala, nuclei basalis, entorhinal
cortex and, in advanced stages, high-order association of the temporal, frontal and parietal regions.
The lesions’ patterns and distribution are usually divided into 6 different stages (I-VI), I being the AD
earlier stage and the VI stage the last one (Fig.1.2) [14].
(a) (b) (c)
Figure 1.2: Most affected brain regions in AD along different stages. (a) Stage I-II: Transentorhinal region
is the first site in cerebral cortex exhibiting alterations in early process of AD. As AD progresses, the lesion
extends to the entorhinal region. (b) Stage III-IV: The lesions become more severe and extend into the fusiform
and lingual gyri. (c) Stage V-VI: The pathology spreads to the frontal, temporal, occipital, peristriate and
striate regions. Adapted from: Braak et al. [14].
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1.1.3 Epidemiology
AD was identified for the first time by Alois Alzheimer, a German physician who in 1906 reported
the case of a woman who presented unusual symptoms that did not fit into any known disease at the
time [16]. Currently, over 35 million people worldwide live with dementia, the majority of whom have
Alzheimer’s. Since the life expectancy is increasing, due to medicine and technology advances, this
number is foreseen to grow in the next years [17]. It is estimated that the number of people living
with dementia will reach more than 100 million by 2050, which makes this condition one of the biggest
global public health concerns [18].
Although the onset of this disorder is not clearly understood, it is suggested that the risk of
developing AD depends on multiple factors rather than a single cause. Age is the greatest risk for
AD development, since the majority of the diagnosed cases appear at age 65 or older. There is also
evidence that the risk of developing AD tends to increase after this age: the estimated annual incident
rate is about 53 new cases per 1000 people aged 65 to 74 years, 75 new cases per 1000 people aged
75 to 84 years and approximately 231 new cases per 1000 to individuals aged 85 years and older [5].
The incidence of AD appears to be greater in women than man (Fig.1.3), which can be explained by
women’s longer life expectancy. On average AD patients have 4 to 8 years of life after diagnosis, but
some can survive as long as 20 years [8].
Figure 1.3: Estimated lifetime risk of developing AD by age and sex. Source: Alzheimer’s disease facts and
figures 2014 [8].
Several studies showed evidence that people with lower level of education seem to have a higher
risk to develop AD compared with those with a higher education. Socioeconomic characteristics and
quality of life also appeared to be relevant factors, which explains why there is a higher prevalence of
AD in countries with a low to middle income (Fig. 1.4).
Severe dementia causes complications which increase the risk of death. The most commonly direct
cause of death of AD patients is pneumonia [17]. Even though the correct account for all deaths which
were caused primarily by dementia is a difficult task, it was estimated that AD is becoming a more
common cause of death. While other common causes of death, such as cancer and HIV conditions
have decreased in the past few years, rate of deaths from AD have increased significantly (Fig.1.5) [8].
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Figure 1.4: Estimated number of people with dementia (millions) until 2050 in high, middle and low income
countries. Source: World Alzheimer Report 2010 [18].
Along with the social impact, dementia also has a great economic impact. Three main sectors
account for costs associated with dementia: costs of medical care, costs of social care, and indirect
costs provided by the patient’s family [8]. The estimated annual social cost of dementia worldwide,
including only direct costs, is US$604 billion [18].
Figure 1.5: Changes (in percentage) in most common causes of death between 2000 and 2010 in United
States. Source: Alzheimer’s disease facts and figures 2014 [8].
According to the World Alzheimer Report 2010 [17], the estimate of population suffering from
dementia in 2010 comprised about 0.5% of the world’s total population [17], making this condition a
current major public health concern worldwide.
1.1.4 Diagnosis - Neuroimaging Techniques
The primary step for dementia diagnosis consists in the doctor’s judgment based on patient’s clinical
history and reports from the individual, family members and friends. The next step involves cognitive
tests and neurological assessment. Although these methods are standard procedures for AD diagnosis,
it can only be definitively confirmed in the autopsy. Despite the existence of medications to relieve
some of the symptoms and slow down the progression of the disease, currently there is no cure for
AD. Therefore, an accurate and early diagnosis is essential in order to delay the progression of the
symptoms before they reach severe states.
6
In 2011, the National Institute on Aging (NIA) and the Alzheimer’s Association proposed a new
approach for AD diagnosis [19] in order to update the guidelines and criteria used since 1984 [20]. This
new approach introduces two considerable changes in the diagnosis criteria: identify three different
stages of AD, the earliest one occurring before symptoms (known as preclinical AD or MCI), and
incorporate biomarkers tests, such as levels of Aβ and tau protein in the Cerebrospinal Fluid (CSF).
Over the last few decades, metabolic and anatomical studies have been evidencing that some brain
regions contribute to early diagnosis of AD, such as the hippocampus and the entorhinal cortex (for ex-
ample [12], [14]). Neuroimaging techniques, such as Magnetic Resonance Imaging (MRI) and Positron
Emission Tomography (PET), are widely used for probable AD diagnosis, since they allow a detailed
anatomical and physiological examination in a non-invasive manner. A more detailed description of
the PET technique, the biomarker used in the present work, is discussed in the following subsections.
FDG-PET
PET is a nuclear imaging technique that uses tracer compounds labeled with positron emitting
radioisotopes which are introduced in the body on a biologically active molecule, allowing the mea-
surement of biochemical and physiological processes in vivo [21]. Fluorodeoxyglucose (FDG) is the
most commonly used tracer. Since brain uses mainly glucose for energy production, labeling glucose
with flurorine-18 allows quantitative measurement of the local metabolism [22]. Glucose metabolism
has been shown to be closely related with neuronal function and functional activity - higher metabolic
activities require higher glucose consumption [23]. Hence, glucose uptake distribution is driven by the
neuronal activity and represents brain integrity, while a reduced glucose uptake represents a reduction
in number of synapses or a decrease in synaptic metabolic activity [22].
FDG-PET was used for AD diagnosis for the first time approximately 30 years ago, and since then
it has been widely applied in research and clinical fields [22]. Several studies found temporal and
parietal hypometabolism, as well as other metabolic lesions, in specific regions, such as the anterior
cingulate cortex, in patients who suffer from AD (for example [24], [25]). Since MCI condition is a
preclinical stage of AD, the AD patients exhibit greater metabolic reductions than the MCI patients
(Fig. 1.6). Longitudinal studies have shown the metabolic change to be progressive both in MCI (that
may decline to AD) and AD patients (for example [26], [27]). Furthermore, recent studies have shown
that AD-like metabolic patterns in MCI patients have higher probabilities to progress to AD within
a certain period of time, which suggests that FDG-PET imaging technique is a powerful tool in early
diagnosis of AD (for example [22], [28], [29]).
Figure 1.6: Representative examples of brain FDG uptake in CN, MCI and AD subjects. In the AD patient,
the arrows indicate the frontal and temporal-parietal regions. Adapted from: G. Small et al. [30].
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1.2 Proposed Approach
The majority of existing CAD schemes for AD rely on the analysis of biomarkers at a single time-
point. However, since AD is a progressive disorder, changes in biomarkers along time could provide
useful complementary information for early diagnosis and progression of AD. The main goal of the
present research is to explore the value of incorporating longitudinal imaging data into the classifier to
improve the discrimination between AD, MCI and CN subjects. The neuroimaging data used in this
work were retrieved from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, including
FDG-PET scans from AD, MCI and CN subjects at baseline, 6-month, 12-month and 24-month follow-
ups.
First, different methods for FDG-PET intensity normalization were explored. This step is crucial
to compare images of different subjects, since the data usually exhibit large intra and inter-individual
variation. Intensity normalization is often performed relative to the Cerebral Global Mean (CGM).
However, this standard procedure conducts to an attenuation of the differences between clinical groups,
which makes the classification task more difficult. Hence, in order to overcome this issue, more suitable
approaches are explored, namely the regional mean and the reference cluster intensity normalization
methods.
The type of features used play a major role in the success of the classifier to distinguish different
clinical groups. Hence, the second intent of this research was to explore two different feature extraction
approaches - multi-region and voxel-based analysis. In the multi-region approach, the brain was
segmented into different regions, and the mean intensity of each region was extracted. In the voxel-
based approach, the intensity of each voxel was used as a feature. Although the first method results in
a well balanced number of features and subjects, which avoids a problem that will be further explained,
the second one has the advantage of avoiding brain segmentation into regions. However, the pattern of
degenerative brain disorders may not follow standard definitions for anatomical or functional regions,
therefore, using ROIs may lead to loss of discriminative information.
When the number of features extracted is extremely high compared with the number of subjects
available, the curse of dimensionality problem arises. This imbalance leads to a performance dete-
rioration of the classifier. In order to deal with this issue, an additional step of feature selection is
required so that only the most discriminative features are selected. Furthermore, selecting only the
most relevant features leads to a better insight of the physiological process described by the data.
Therefore, the advantages of feature selection in the classification task were tested using three different
methods: t-test, linear correlation and mutual information.
Finally, in order to investigate the value of the longitudinal information, three different types of
datasets were used for the classification: datasets containing only single-time point FDG-PET scans;
datasets containing only the changes of the scans over the follow-up period; datasets combining, by
simple concatenation, single-time point scans and longitudinal changes.
A Support Vector Machine (SVM) algorithm was used as classifier. Linear and radial basis function
kernels were tested in SVM, when the voxel-based and multi-region analysis were performed, respec-
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tively. Nested-cross validation procedure was applied in order to tune the classifier parameters and to
estimate its performance. Considering the fact that an early diagnosis of dementia is crucial, classifica-
tion experiments were performed not only to distinguish CN and AD subjects but also to differentiate
CN/MCI and MCI/AD individuals.
1.3 Original Contributions
The research in the present thesis brings contributions within the scope of image-based classification
of AD and MCI. Recently, some studies have been investigating the value of incorporating longitudinal
imaging data for the classification of AD and MCI (for example [31], [32], [33]). Nevertheless, these
studies concluded that this information alone did not provide improved classification results compared
to using cross-sectional data. Gray et al. in 2012 [33], using a multi-region approach, attempted to
combine single-time point scans and changes over a 12-month follow-up period, demonstrating the
value of longitudinal information. In the present work, this approach was extended to the entire brain
pattern. Hence, a voxel-based approach is proposed, which avoids brain segmentation into regions of
interest. Furthermore, the multi-region analysis was also tested, but unlike the work of Gray et al.
[33], different feature selection methods were applied in order to select only the most discriminative
brain regions for classification. In addition to baseline, other three follow-up FDG-PET scans were
explored for classification, namely the 6-month, 12-month and 24-month imaging data.
Regarding the FDG-PET intensity normalization, several studies have been evaluating different
methods (for example [34], [35]). The reference cluster method proposed by Yakushev et al. [34], has
been widely used since it has proved to increase the discrimination between different clinical groups.
In the present thesis, an approach also based on the reference cluster method is proposed.
From the results obtained in the present thesis, a paper entitled ”Longitudinal FDG-PET Features
for the Classification of Alzheimer’s Disease”, written in cooperation with my advisor Prof. Mar-
garida Silveira, was submitted and accepted in the 36th Annual International Conference of the IEEE
Engineering in Medicine and Biology Society, Chicago.
1.4 Thesis Outline
The most important contributions in CAD schemes for AD are summarized in Chapter 2. The role of
FDG-PET as biomaker is highlighted as well as the recent growing interest in longitudinal information
analysis. The methods used in the present work, including FDG-PET intensity normalization, feature
extraction and selection are explained in detail in Chapter 3. A description of the basic concepts and
mathematics of SVM is also presented, as well as of the nested-cross validation procedure for parameter
optimization and the classification performance assessment. The experiments and results obtained are
described in Chapter 4. Finally, Chapter 5 concludes the present thesis, discussing the results, the
main research contributions and future work.
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State of the Art
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The uncertainty and subjectivity underlying medical image analysis and interpretation led to the
development of computerized systems aiming to assist clinicians. CAD schemes have been widely used
as a complement to the physician’s diagnosis in order to improve accuracy performance, mainly in
cancer detection [36]. The success of this implementation led to a growing interest in expanding CAD
schemes to other medical fields. In the last few years, several research programs have focused on the
development of these systems to distinguish different types of dementia and to diagnose MCI, AD
and other neurological disorders such as Parkinson disease, Lewy body dementia and frontotemporal
degeneration [37].
The construction of a CAD scheme is usually based on a supervised learning strategy, i.e., an
hypothesis is learned from labeled data, and the label of a new unseen example is determined. The
labeled data consists on a set of diagnosed samples, e.g., a set of medical images from healthy subjects
and from patients diagnosed with a certain pathology. The labeled data used to train the model is called
training data set, and the set where the constructed model is validated is called test (or validation)
set. CAD systems involve feature extraction from images used as training data and construction of a
predictive model with a machine learning algorithm capable of classifying a new individual image as
healthy or pathological. These systems can be constructed using only image-based information or in
combination with other relevant biomarkers. The most common methods involved in the construction
of CAD systems for AD will now be briefly described (a more detailed explanation of some of these
procedures will be presented in Chapter 3).
A biomarker is a biological feature measured in vivo that indicates the presence or absence of
a certain pathology. Since the criteria for AD diagnosis was established for the first time in 1984
[20], significant progress has been made in the identification of AD-associated brain changes and
the incorporation of new biomarkers has been proposed [19]. Current biomarkers for AD include
biochemical, neuroanatomical, metabolic, genetic and neurophysiological features. MRI and FDG-
PET are widely used neuroimaging techniques in several proposed CAD schemes for AD. FDG-PET
proved to be very sensitive to synaptic dysfunction and hypometabolism revealing the presence of
neuropathologies before the atrophy of certain structures of the brain detected with MRI technique
[22]. Nevertheless, MRI is also widely used in CAD systems for AD, since it has been shown to be
very efficient in distinguishing AD subjects from healthy controls or patients with other neurological
disorders [38]. Other neuroimaging techniques such as Single Photon Emission Computed Tomography
(SPECT) is also explored in various studies (for example, [39], [40]). In addition to neuroimaging data
for AD automatic diagnosis, the incorporation of other biomarkers including CSF levels of tau protein,
which reflects the brain increase deposition of Aβ, and genetic factors, such as the presence of APOE
genotype, was also suggested in several studies (for example, [31], [32] ).
Feature extraction is a crucial step for CAD schemes since it implies extracting relevant information
from medical images, which have great influence on the success of the classifier to identify pathological
conditions. Different feature extraction methods have been proposed but the most simple and direct
method is the extraction of the Voxel Intensity (VI) values from the whole brain or from a Region of
Interest (ROI). Usually, a problem arises with the whole brain approach due to the number of features
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highly exceeding the number of samples, the so called curse of dimensionality. Thus, a feature selection
step is usually implemented in order to ascertain which of the features are relevant for the classification
task. Several feature selection methods have been proposed in recent years. Filter methods are one
of the most simple and most used approaches. These methods assess the relevance of each feature, in
order to decide whether it should be incorporated in the learning stage. Mutual information, correlation
coefficients and t-test statistics are some examples of this class of algorithms used as feature selection
methods in CAD systems proposed for AD. A detailed description of the aforementioned approaches
will be presented in Chapter 3.3.
Regarding the classification task, the majority of the classification methods found in the literature
are based on SVM. SVM is a supervised learning algorithm for binary classification, i.e., given a
training data classify new unseen examples into one of two classes. A detailed explanation of this
algorithm will be addressed in Chapter 3.4.
A chronological review of the most relevant contributions for automatic diagnosis of AD, including
a brief description of the methods and principal results obtained, is now presented.
In the past few years, several CAD schemes for AD have been proposed using different neuroimag-
ing techniques. The beginning of the new millennium marked a new era in this field, since before that
the majority of the research only aimed to study brain differences between AD and CN subjects, not
providing a tool capable of classifying, in an automatic manner, a new individual image. In 2002,
Herholz et al. [25] conducted one of the largest multi-center studies accomplished so far. The aim was
the development of a fully automated method for FDG-PET images analysis in order to discriminate
between CN and AD patients based on a Statistical Parametric Mapping (SPM) approach. An age cor-
rection was performed in the measured FDG uptake in each image and t-maps were calculated between
CN and AD clinical groups. A score was computed for each individual image as the voxel-by-voxel sum
of all t-values of the voxels with FDG uptake below 95% age-adjusted prediction in predefined areas
typically affected by AD. Hence, a score higher than an established threshold indicates an abnormal
metabolism. This score was shown to be highly susceptible to scan abnormalities, reporting 93.0% of
sensitivity and specificity and 97.0% of accuracy to distinguish CN from AD subjects. Although the
method proposed by Herholz et al. led to very optimistic results and was adopted in several other later
studies, this approach requires a priori knowledge about the disease process which may be a drawback.
In 2005, Stoeckel et al., [40] proposed an automatic classification method, based on SPECT imaging
data, that avoided explicit knowledge about the disease patterns. Rather than simply selecting the
most relevant voxels for classification, as the same group has done in a previous work [41], they also
incorporated spatial information, generating a classifier that selected the most relevant areas giving a
better insight into the physiological patterns of AD. Thus, a contiguous-SVM was proposed as classifier
where the model depended on clusters of voxels rather than on isolated ones. They also compared
these results with the sensitivity and specificity of the diagnosis based on visual analysis of the SPECT
images by expert physicians. The proposed automatic method achieved a sensitivity of 84.4% and
90.0% of specificity, which outperformed the human analysis.
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Since AD is a progressive neurodegenerative disorder, discrimination of different stages of the
disease has received increasing attention and MCI patients have been included in several studies. In
some of these studies, which will be referred to later, a distinction between MCI patients that declined
to AD (MCI converters), and MCI patients that remained stable over a certain period of time (MCI
non-converters) was also incorporated. In the work of Davatzikos et al. [42] in 2006, a high-dimensional
MRI image analysis and pattern classification method was proposed to identify MCI subjects. The
MRI images were segmented into gray matter, white matter and CSF. The Pearson-correlation was
calculated between each voxel and the class label in order to estimate the specific patterns of MCI
condition. In order to retain spatially-meaningful regions, among the features with best values of this
coefficient only the ones with spatial consistency with its neighborhood were used as features. A SVM
recursive feature elimination was also applied in order to discard less relevant features, achieving an
accuracy of 90.0% in the discrimination of CN and MCI subjects. In this work, Davatzikos et al.
demonstrated that the subtle structural patterns that characterize the brain of individuals suffering
from MCI can be identified from MR scans via high-dimensional analysis and pattern classification
methods.
Other studies, in an attempt to gather more meaningful information from a physiological point of
view, selected specific brain regions for classification rather than the whole brain. These regions are
tipically brain structures or areas known to be affected in AD, such as the hippocampus. In 2008,
Colliot et al. [43] developed an automated method for hippocampus segmentation on MR images, and
compared this method with manual segmentation. Hippocampal volume differences between groups
were assessed using t-test statistics. For classification, a bootstrap method was applied, which consisted
on using approximately 75% of the imaging data of each group to obtain a training set and estimate
the mean of hippocampal volume. The remaining 25% were used as test set, and the procedure was
repeated 5000 times. Each case of the test set was assigned with the closest group, i.e, the group
that had the hippocampal volume mean closer to the example being tested. This procedure led to an
accuracy of 84.0% classifying AD from CN subjects, an accuracy of 73.0% classifying MCI from CN
subjects and an accuracy of 69.0% classifying MCI from AD subjects. Although the hippocampus is
one of the most affected brain structures at earlier stages of AD, there are other regions which are
affected as the disease progresses. Hence, some studies focused on finding the most affected regions
using different types of neuroimaging techniques in order to use them for classification. Magnin et al.,
in 2009 [44] proposed an automated method to discriminate AD and CN subjects, using a whole-brain
segmentation approach from MR images. The whole brain was segmented into 90 anatomical regions,
and a t-test was conducted to find the most discriminative regions. An accuracy of 94.5% (91.5% of
sensitivity and 96.6% of specificity) was obtained using this approach.
As one can observe, some methods suggested in the aforementioned studies seem to have more
success than others. However, this comparison is very difficult to assess since the database used by
different studies is usually not the same. Concerned by this observation, Cuingnet et al., in 2011 [45],
compared the performance of several different high-dimensional classification methods on the same
dataset using 10 different approaches, including whole brain and ROI methods. SVM was used as the
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learning algorithm since it is the most commonly used classifier. They concluded that for distinguishing
AD from CN, whole brain methods had more success, yielding a higher accuracy. On the other hand,
for classifying MCI from CN, hippocampus based methods remained closer to whole-brain methods
results. This outcome suggest considering the whole brain may be a more advantageous approach at
more advanced stages of the disease.
Currently, a multi-modality approach is emerging. Noticing that different biomarkers provide
complementary information valuable to distinguish AD, MCI and healthy individuals, attracted great
interest to the investigation of multiple biormakers combination. In 2011, Zhang et al. [32] combined
MRI, FDG-PET and CSF biomarkers to discriminate between AD, MCI and CN subjects. For each
MRI and FDG-PET image, 93 features were extracted corresponding to 93 anatomical brain segmented
regions, and linear SVM was used as classifier. An accuracy of 93.2% was achieved for classifying AD
from CN subjects when combining all the three modalities, and only 86.5% of accuracy was achieved
when using the best individual modality alone. To distinguish MCI from CN individuals, a classification
accuracy of 76.4% was obtained against 72.0% of accuracy when using only the best modality. In this
study, a distinction between MCI subjects who convert to AD within 18 months and MCI subjects who
remained stable during the same period of time was also considered, and 91.5% of MCI converts and
73.4% of non-converts were correctly classified using the multi-modality approach. The results obtained
in this study highlighted the value of combining different biomarkers for the automatic detection of
MCI and AD conditions.
More recently, the potential of incorporating longitudinal information for classification has been
evaluated. Chen et al. [27] compared the decline of brain metabolic rate over 12 months in AD, MCI
and CN patients, using FDG-PET imaging data. In their study, the most discriminative ROIs between
groups, i.e., the voxels of the regions consistently associated with longitudinal change, were used. The
ROIs were defined using independent two-sample t-test to evaluate which were the more discriminative
regions between subjects of each group. In their longitudinal analysis, significant group differences
between AD, MCI and CN subjects were reported, which encouraged further longitudinal analysis.
In 2011, Hinrichs et al. [31] suggested a multi-modality approach, incorporating cross-sectional and
longitudinal MRI and FDG-PET imaging data, clinical measures (CSF and APOE genotype) and
neurophysiological status information, using kernel combination methods. As in the work of Zhang et
al. [32], they also reported a higher accuracy for multi-modality approach, compared with using any
individual biomarker. For their longitudinal analyses, a baseline and a 24-month follow-up MRI and
FDG-PET scans were included. They observed that longitudinal analysis of the FDG-PET images had
poor discriminative ability, since neither of the two methods considered (voxel-wise temporal differences
and voxel-wise temporal ratio) had an accuracy higher than 65.0%. These results suggested that the
changes over a 2-year period alone do not provide sufficient information to identify AD with accuracy.
Actually, due to this poor performance, they decided not to include the longitudinal information in
their final classifier. In 2012, Gray et al. [33] also explored the value of combining cross-sectional
and longitudinal multi-region information for classification. Whole-brain segmentation into 83 regions
was performed for baseline and 12-month FDG-PET images. The signal intensity of the baseline and
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12-month images and signal intensity changes over 12 months for the 83 regions were used as features.
Classification accuracies of 88.0% between AD and healthy controls, 81.3% between CN and MCI
converters, 83.5% between CN and MCI non-converters and 63.1% between MCI converts and MCI
non-converts were achieved by combining cross-sectional and longitudinal information. These results
were significantly higher than the ones obtained using cross-sectional data alone, which suggests that
longitudinal information may provide valuable complementary information and consequently improve
the classification performance.
The current tendency towards a multi-modality combination approach raised an important question
related to feature selection. This step is usually performed separately for each modality which ignores
the inter-modality relation that gives different yet complementary information. To address this issue,
Liu et al., in 2013 [46] proposed a novel approach to multimodality feature selection. The aim was
to preserve the complementary information and the relationship between the features derived from
different biomarkers. The brain was segmented into 93 ROIs, and gray matter volume of each ROI
was extracted as the features for MRI modality and the averaged intensity of each ROI was used
as the features for PET modality. The method consisted firstly in treating features from different
modalities as different tasks, and then a constraint was imposed in order to preserve the inter-modality
relationship. For combining the selected features, a multi-kernel SVM was used. The key of multi-
task learning approach relies on the capture of intrinsic relationship between different tasks, exploiting
the commonalities between them. An accuracy of 94.3% was achieved for classifying AD from CN
subjects, and an accuracy of 78.8% for classifying MCI from CN subjects. A classification beetween
MCI converters and non-converters was also assessed, yielding an accuracy of 70.0%, outperforming
the results obtained by using other state-of-the-art methods.
A summary of the aforementioned studies is present in table 2.1 .
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Author(s),
Year
Biomarker(s) Methods
Participants *Results (%)
Main Purpose
CN AD MCI ACC SENS SPEC
Herholz et al.,
2002 [25]
FDG-PET SPM 110 395 - 97.01 93.01 93.01
Automatic method
to detect abnormal
brain metabolism
Stoeckel et al.,
2005 [40]
SPECT
Contiguous
SVM
99 31 - - 84.41 90.01
Incorporation of
spatial information
about the features
into the classifier
Davatzikos et al.,
2006 [42]
MRI
Pearson
Corr. Coef.,
SVM
15 - 15 902 - -
High dimensional
image analysis and
pattern classification
methods to identify
MCI subjects
Colliot et al.,
2008 [43]
MRI
Hippocampus
segmentation,
Bootstrap
25 25 24
84.01
73.02
69.03
84.01
75.02
67.03
84.01
70.02
71.03
Automatic
segmentation
of the hippocampus
on MR images
Magnin et al.,
2009 [44]
MRI
Whole-brain
segmentation,
SVM
22 16 - 94.51 91.51 96.61
Whole-brain
anatomical
segmentation of MR
images
Cuingnet et al.,
2010 [45]
MRI
Whole-brain,
hippocampus
segmentation,
SVM
162 137 213 -
81.01
73.02
95.01
74.02
Comparison of
different
classification
methods
Zhang et al.,
2011 [32]
FDG-PET
MRI
CSF
ROI,
SVM
52 51 99
93.21
76.42
93.01
81.82
93.31
66.02
Combination of
multiple biomarkers
for classification
Hinrichs et al.,
2011 [31]
FDG-PET
MRI
CSF
APOE
Multi-kernel
learning
66 48 119 92.41 86.71 96.61
Combination of
multiple biomarkers
and multi-kernel
learning for
classification
Gray et al.,
2012 [33]
FDG-PET
ROI,
SVM
54 50 117
88.01
81.32
83.53
63.14
83.21
79.82
79.93
52.24
96.31
82.92
86.43
73.24
Combination of
cross-sectional
and longitudinal
information for
classification
Liu et al.,
2013 [46]
PET
MRI
Multi-kernel,
SVM
52 51 99
94.41
78.82
67.84
94.71
84.92
64.94
94.01
67.12
70.04
Multi-task
feature selection
to preserve
inter-modality
information
Table 2.1: Chronological summary of some proposed CAD systems for AD since 2002. Biomarkers, method and participants
used by each study are present, along with the main results obtained (ACC-accuracy; SENS-sensitivity; SPEC-specificity).
The last column resumes the main goals/contributions of each study.
*Results present are the best results achieved in each study. The superscript numbers follows the scheme:
1 - CN vs AD; 2 - CN vs MCI; 3 - MCI vs AD; 4 - MCI converters vs MCI non-converters.
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In the present chapter, the fundamental steps required for the construction of the proposed CAD
scheme are described, which include the FDG-PET intensity normalization, feature extraction, fea-
ture selection and classification. Intensity normalization of the FDG-PET images is an important
preprocessing step. In order to elect the most suitable normalization method for the study popu-
lation, different approaches were tested and a description of these methods is presented in Section
3.1. The next step involved in the construction of the CAD scheme was the extraction of features
from the FDG-PET images. Two approaches were investigated in the present work: multi-region and
voxel-based analysis. They are both described in Section 3.2 for cross-sectional and longitudinal data.
Regarding the feature selection step, three different methods were tested, namely the correlation co-
efficient, the t-test and the mutual information. A detailed description of these methods is presented
in Section 3.3. Finally, the classification task was accomplished with a SVM algorithm whose basic
concepts and mathematics are introduced in Section 3.4.
3.1 FDG-PET Intensity Normalization
The Cerebral Metabolic Rate of Glucose (CMRgl) of cognitively healthy individuals and patients
suffering from a neurological disorder exhibit large inter and intra-individual variation. Hence, intensity
normalization of FDG-PET images is a crucial preprocessing step in order to allow direct comparison
of the data. Several studies (for example, [35], [47], [48]) investigated the effect of using different
intensity normalization methods, reporting significant impact in the classification results. Three main
approaches have been applied, namely the CGM, the regional mean and the reference cluster intensity
normalization. The most commonly used method is the CGM intensity normalization, which uses the
whole brain to normalize the images, contrary to the regional mean intensity normalization approach
which normalizes the data using only a specific brain region. More recently, a reference cluster approach
has been proposed, which is based on a data-driven procedure.
The following subsections present a detailed description of the aforementioned methods.
3.1.1 Cerebral Global Mean Intensity Normalization
Ratio normalization of the regional FDG uptake relative to the CGM has been the most frequently
used method. It consists on the division of the intensity value of each voxel by the mean intensity of
all intracerebral voxels. When applying this procedure, there is the fundamental requirement that the
cerebral global mean does not vary significantly between the different clinical groups. However, this
imposition is usually violated in neurodegenarative disorders, such as AD, which have lower CMRgl
relative to healthy subjects since the former have the normal neuronal function compromised. Thus,
this process conducts to an attenuation of the differences between clinical groups, since the intensity
signal of FDG-PET images from patients are artificially scaled up while those from healthy individuals
are scaled down. Therefore, this type of normalization leads to an apparent hypometabolism in healthy
subjects in regions that are known to be relatively spared in AD.
20
3.1.2 Regional Mean Intensity Normalization
Recent studies suggest that using specific brain regions rather than the CGM for normalization
avoids the bias introduced by the CGM method, leading to an improvement of clinical groups discrim-
ination (for example, [24], [34], [35]). The selected regions are brain areas identified by several studies
(for example, [25], [49]) as the most preserved by the disease process, such as cerebellum, brainstem,
basal ganglia and Sensorimotor Cortex (SMC). However, these methods require the selection a priori
of one of these spared areas, based on the assumption that one of these brain regions is the most
appropriate to normalize a certain study population.
3.1.3 Reference Cluster Intensity Normalization
In contrast with the previous methods, a data-driven approach based on an iterative procedure to
define the region used for normalization a posteriori was originally proposed in 1997 by Andersson
[50]. This method aimed to avoid the bias introduced by the CGM approach when performing PET
activation studies. Additionally, the chosen region depends directly on the data being analyzed which
also avoids the a priori definition of a region. More recently, Yakushev et al., in 2009 [34] proposed
a similar data-driven method, but unlike the original algorithm [50] that uses multiple iterations, this
method uses only two iterations. In the first one, the standard CGM normalization is performed. As
previously explained (Section 3.1.1), this procedure leads to the appearance of hypermetabolic voxels
in the pathological group compared to the healthy control in preserved brain regions. In the second
iteration, a t-test is conducted in order to find the apparently hypermetabolic regions in the patient
group compared to the healthy one. The result of this analysis is expressed by a SPM map, where each
voxel is defined by a t-statistic. A threshold for the t-value and for the spatial extent of contiguous
voxels is applied. The voxels which fulfill the imposed constrains constitute the clusters and the cluster
containing the voxel with the highest t-value is used as reference cluster. The mean value of the voxels
of the reference cluster is then extracted and the voxels of each individual image are multiplied by the
mean value of the corresponding cluster-derived. Hence, this method selects only the most preserved
brain area in a study population. Due to its clear advantages and positive influence on the performance
results, this method has been widely adopted in several recent studies aiming to discriminate CN from
AD and MCI subjects (for example, [33], [51]) and also from other neurodegenerative disorders (for
example, Frontotemporal Lobar Degeneration [52], Parkinson’s Disease [53]).
3.2 Feature Extraction
The feature extraction step is a critical procedure that transforms the input data into vectors
that must contain all of the relevant information regarding the detection of pathological conditions.
Since the original neuroimaging data is extremely high-dimensional but generally a small sample size
is available, the feature extraction can also be applied to reduce the amount of input data in order to
overcome the curse of dimensionality (see Section 3.3). A commonly used method to reduce the input
features dimensionality is to group voxels into multiple anatomical regions (multi-region) rather than
to use single voxels as features (voxel-based). In the present thesis, a multi-region and a voxel-based
analysis were explored for extracting the features from the cross-sectional and longitudinal data.
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3.2.1 Cross-sectional Features
Regarding the feature selection for FDG-PET data, the VI-based analysis is the most simple and
direct method used. The VI in the FDG-PET modality represents the CMRgl, which is related to
neuronal function (see Section 1.1.4). Two main approaches can been applied: extraction of the VI
values from the whole brain (voxel-based analysis) or from one or multiple ROIs (multi-region analysis).
In the voxel-based analysis, intracerebral VI of the whole brain are extracted and used as input features
for the classifier (Fig. 3.1).
Figure 3.1: Illustrative example of a brain FDG-PET scan (transaxial view). On the left image, the FDG-
PET scan with a colorbar indicates the intensity of each voxel, i.e., the FDG uptake. Blue colors represent
lower levels of CMRgl whereas warm colors indicate higher levels of CMRgl. On the right, an image of the
same FDG-PET scan with the extracerebral voxels removed is illustrated.
Although the whole brain approach has been reported to be more beneficial for most advanced
stages of the disease [45], the ROI approach has been widely used due to its advantages. Extracting
only the most discriminative brain regions leads to a dimensionality reduction of the features vectors,
which have a great influence in the algorithm performance and can save computational cost. On the
other hand, this method requires the choice and extraction of the regions, which is a time-consuming
and user-dependent task. In order to overcome these drawbacks, several anatomical atlas based on
MRI scans have been developed (for example, [54], [55]) as well as automatic segmentations of certain
regions of the brain, such as the hippocampus (for example, [56], [57]). In the present thesis, an
atlas developed by Desikan et al. [55] was used in the multi-region approach. This atlas automatically
segmented the whole brain into 34 cortical ROIs in each hemisphere plus the brainstem, using a dataset
of 40 MRI scans (Fig. 3.2). A total of 69 regions across whole brain are encoded in the atlas. For
the regional analysis, the mean of the voxels intensity of each region was extracted, a totaling of 69
features for each subject. In Fig. 3.3, an example of the brain segmentation of an FDG-PET scan
using the adopted atlas is illustrated.
3.2.2 Longitudinal Features
The incorporation of longitudinal information for the automatic diagnosis of AD only recently
begun to receive some attention (see Chapter 2), therefore feature extraction for longitudinal data is
not a widely investigated topic. In the present thesis, a simple and intuitive method for longitudinal
feature extraction is proposed. The longitudinal information is comprised by the baseline, 6-month,
12-month and 24-month FDG-PET follow-up scans of each subject. Similarly to the extraction of the
cross-sectional features, the extraction of the longitudinal features was performed using a voxel-based
and regional-based analysis. In the voxel-based approach, the differences between baseline VI and VI
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Figure 3.2: Representation of some of the labeled ROIs in the brain hemisphere encoded in the Atlas
developed by Desikan et al. [55]. The left image illustrates the lateral view of the hemisphere and the right
image illustrates the medial view of the hemisphere. Adapted from: Desikan et al. [55].
of corresponding voxels in the follow-up scans were extracted. Hence, different sets of features were
obtained: VI differences between baseline and 6-month scans, VI differences between baseline and
12-month scans and VI differences between baseline and 24-month scans. The result of this procedure,
using the 24-month follow-up scans, is illustrated in Fig. 3.4. As one can observe, the brain extension
and value of the differences over a 24-month period are larger for AD patients compared to the CN
subjects. Furthermore, a closer look can detect a decline in the intensity of the images between groups
at the baseline and 24-month follow-up scans. Regarding the regional-based analysis, all time points
scans were first segmented into ROIs, using the above mentioned anatomical atlas. Then, the mean
VI of each region, in each time-point scan was computed. Finally, the regional differences between the
baseline and the follow-up scans were extracted for each subject, originating different sets of regional
longitudinal features.
Figure 3.3: A transaxial view of a FDG-PET scan illustrating the brain segmentation into different ROIs. On
the left, an FDG-PET scan containing only the intracerebral voxels is present. On the right, the anatomical
masked segmentation into different cortical regions with a distinction between the regions localized in the left
and right hemispheres is illustrated. Different colors correspond to different regions.
It is assumed that the differences extracted reflect the CMRgl decline along time. Hence, higher
differences correspond to brain regions where neuronal degeneration is more intense, and lower differ-
ences correspond to brain regions that are relatively spread by the disease process along time. It is
also expected that the signal intensity differences between the baseline and 24-month scans are more
pronounced than the signal intensity differences between baseline and 6-month or 12-month scans,
since AD is a progressive disease and neuronal degeneration worsens over time.
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Figure 3.4: Transaxial sections of FDG-PET brain scans at the baseline, 24-month and the VI change over
24 months from CN, MCI and AD subjects. The 24-month changes are computed by subtracting the VI of
the 24-month scans from the VI of the baseline scans. For the cross-sectional scans, warmer colors indicate
higher FDG uptake and blue colors indicate lower FDG uptake. In the third column, the warmer colors in
the images indicate higher metabolic differences along the 24-month period and blue colors indicate relatively
preservation of the metabolism along this period.
3.3 Feature Selection
Feature selection is a crucial data preprocessing step, in particular when the number of features
highly exceeds the number of available samples, a situation commonly refered to as the curse of
dimensionality. Under these conditions, the classifier tends to overfit the data and the generalization
ability is compromised, leading to a deterioration of the classifier performance. Furthermore, the
features extracted may contain noisy data, irrelevant and redundant information, which can have a
great influence on the final outcomes. Additionally, a high-dimensional input features tends to be
computationally expensive. Hence, the ultimate goal of the feature selection step is to select the
smallest subset of features that maximally increases the performance of the classifier, providing an
acceptable trade-off between the results and the computational cost. Besides improving the accuracy
results, feature selection techniques also provides a better insight of the processes described by the
data, since only the relevant features are used as input for the classifier.
Feature selection techniques for machine learning typically fall into two categories, namely filter
methods and wrapper methods, depending on how the algorithm interacts with the classifier [58].
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Filter methods are directly applied on the dataset selecting a specific number of features according to
some ranking score. Wrapper methods assess the quality of a set of features guided by the outcome
of the classifier itself. Wrapper methods usually yield higher predictive accuracies than filters since
the former optimize the feature selection process according to the results obtained with the learning
algorithm employed. However, applying a learning algorithm to evaluate the classification results
using every set of features is extremely expensive from a computational point of view. On the other
hand, filter methods that treat each feature independently scoring them according to its discriminative
power, are very efficient and fast to compute. However, a feature that is not useful alone, may provide
valuable information when combining with other features, and unlike wrappers, the filter methods
do not capture this relationship. Still, the advantages of filter methods, especially in a voxel-based
analysis where the number of features are extremely high, may outweigh their disadvantages in some
particular situations. For these reasons, only filter methods are explored in the present thesis and they
are described in the following subsections.
3.3.1 Correlation Coefficient
The feature selection scheme based on the correlation coefficient consists on computing the correla-
tion between each feature and the class label. The value obtained reflects the relevance of each feature
to identify the clinical group.
In the present work, the correlation coefficient used was the Pearson’s linear correlation. Consider
a vector vj containing the intensities of the j-th voxel across K subjects and a vector y containing
the correspondent class label for each subject (y = -1 for healthy control subjects and y = 1 for
pathological subjects (AD or MCI)). Pearson’s correlation coefficient r at the j-th voxel is computed
as follows:
r(vj ,y) =
K∑
i=1
(vij − vj)(yi − y)√
K∑
i=1
(vij − vj)2
√
K∑
i=1
(yi − y)2
, (3.1)
where vij is the value of the j-th voxel in the i-th FDG-PET image, and yi is the class label (-1 or 1)
of the corresponding i-th image. Hence, each voxel is characterized by a correlation coefficient with
values comprised between -1 and 1, where -1 corresponds to a total negative correlation, 1 indicates
a total positive correlation and 0 means no relationship between the feature and the label. Features
with highest absolute correlation coefficient are selected as input to the classifier.
3.3.2 t-Test
The t-test is a statistical test used to assess whether the means of two populations are statistically
different from each other. In other words, this method tests the null hypothesis that data from two
populations comes from independent samples from normal distributions with equal means and equal
but unknown variances. The alternative hypothesis is that the two populations have different means.
The t-test returns a t-value which computes the mean differences between the two populations. Thus,
the higher the value of t, the larger are the confidence to reject the null hypothesis. This test also
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returns a p-value which is a scalar with values comprised between 0 and 1, inclusive. The p-value
reflects the probability, under the assumption that the null hypothesis is true, of obtaining a given
result, or one more extreme, by chance. The null hypothesis is rejected when the p-value is lower than
an established significance level, usually 0.05.
The t-test has been widely used as feature selection method in order to select the most discriminative
voxels between CN and AD or MCI subjects, in several published papers (for example [25], [41], [59]).
This statistical test compares images from different clinical groups using a voxel-by-voxel analysis. A
SPM of the group’s differences is therefore generated, identifying regions where the pathological group
has reduced CMRgl as compared to the cognitively healthy group. In the present thesis, an unpaired
two-sample t-test was conducted between different pairs of clinical groups (CN vs AD, CN vs MCI,
MCI vs AD). The t-value is estimated as follows:
tj =
Iy−1 − Iy1
Sy−1y1
√
1
k−1
+ 1k1
, (3.2)
where tj is the t-value of the j-th voxel, Iy-1 and Iy1 denotes the mean voxel intensities of the FDG-PET
images of the subjects labeled as y = -1 and y = 1, respectively, k -1 and k1 denotes the number of
subjects labeled as y = -1 and y = 1, respectively. Sy-1y1 is the estimation of the common standard
deviation of the two samples and it is calculated as:
Sy−1y1 =
√
(k−1)S2y−1 + (k1 − 1)S2y1
k−1 + k1 − 2 , (3.3)
where Sy-1 and Sy1 are the sample standard deviation image for the population labeled as y=-1 and
y=1 respectively, and it is defined as (i=-1,1):
Si =
√√√√ 1
ki − 1
ki∑
j=1
(Ij − Iyi)2 (3.4)
In the present work, the voxels of the FDG-PET images are ranked using the absolute t-value obtained
by the t-test. A higher t-value indicates significant differences between the mean of the healthy control
group and the pathological group (MCI or AD) which is related to the decline of CMRgl. Hence, the
t-test selects the most discriminative features between clinical groups, i.e., the voxels were the brain
FDG uptake is compromised due to the disease process.
3.3.3 Mutual Information
Mutual information is a nonparametric measure of the mutual dependence of two variables, i.e., it
represents the reduction in uncertainty about a certain variable x when the value of a variable y is
known. The mutual information as feature selection method has been proposed [60], since it assesses
the information content of the features.
The mutual information of two random variables x and y is defined in terms of their respective
26
probabilistic density function p(x) and p(y) and their joint density function p(x,y):
MI(x, y) =
∫
x
∫
y
p(x, y)log
p(x, y)
p(x), p(y)
dxdy, (3.5)
Hence, MI(x,y) estimates the dependency between the density of variable x and y. Observing Eq. 3.5,
if x and y are independent, then p(x,y) = p(x)p(y), therefore their mutual information is 0, which
means they contain no information about each other.
When the variables are discrete, their probabilities are estimated by frequency counts and Eq. 3.5
is rewritten as:
MI(x, y) =
∑
x
∑
y
P (x, y)log
P (x, y)
P (x)P (y)
(3.6)
The probabilities densities can be approximated using histograms. In the present thesis, the features
with higher mutual information values were selected, since they reflect a stronger dependency on the
class label, hence a higher discriminative power.
3.4 Classification - Support Vector Machines
Support Vector Machines (SVMs) are a set of machine learning algorithms introduced by Boser,
Guyon and Vapnik in 1992 [61]. Currently, SVM is one of the most used classifier in a wide range
of applications, due to its high performance even when dealing with high-dimensional data. SVMs
algorithms are based on supervised learning that uses training data to build a model able to predict the
class of a new sample. The evaluation of the classifier performance along with parameter optimization
is essential in order to validate the obtained model. Nested cross-validation is one of the most popular
methods and the one used in the present work. A detailed description of this procedure and the basic
concepts and mathematics of SVMs are now presented.
3.4.1 Basic Concepts and Mathematics
The concept behind SVM algorithm relies on the construction of a hyperplane which separates a
set of binary labeled training data with maximal margin between the vectors of the two classes (known
as maximum margin hyperplane). Only a small number of training vectors are necessary to determine
this margin in order to construct the hyperplane, the so called support vectors. The construction of
this hyperplane is illustrated in Fig. 3.5, for two linearly separable classes which is the simpler possible
scenario.
If the training data are separated by an optimal hyperplane without errors, the expected probability
of committing an error on a test example is given by the ratio between the value of the expected number
of support vectors and the number of training vectors:
E[P (error)] ≤ E [number of support vectors]
number of training vectors
(3.7)
As one can observe, the expected error does not explicitly depend on the dimensionality of the feature
vector. Hence, if a small number of support vectors relative to the training data size is used to construct
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Figure 3.5: Illustration of the concept of maximum margin hyperplane used by SVM algorithm. The algorithm
searches for a boundary that maximizes the distance of the closest points of each class. These points are called
support vectors.
the hyperplane, the generalization ability of the classifier is large, even for high-dimensional data. The
mathematics behind the implementation of SVM algorithm will be addressed next. A more detailed
explanation can be found in [62].
Consider a set of linearly separable training samples S = {(x1, y1), ..., (xk, yk)}, where x∈ Rn
denotes the input space and y ∈ {−1, 1} the output domain for binary classification. The optimal
hyperplane in the feature space that separates the two classes can be parameterized by its normal
vector w and a constant b:
w · x + b = 0 (3.8)
Given this hyperplane, the decision function is defined as:
f(x) = sign(〈w · x〉+ b) (3.9)
The two classes are linearly separable if there is a vector w and a scalar b that satisfies the following
conditions:
w · xk + b > 1 if yk = 1,
w · xk + b 6 −1 if yk = −1, (3.10)
The inequalities 3.10 can be rewritten in the form:
yi(w · xk + b) > 1 ∀k (3.11)
Since the optimal hyperplane is the one that separates the two classes with a maximal margin, this
distance is given by:
d((w, b), xk) =
yk(w · xk + b)
|| w || (3.12)
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In order to obtain the minimum distance between support vectors, which corresponds to maximiz-
ing the margin, Eq. 3.12 must be minimized by optimizing the parameters w and b. This can be
formulated by the following optimization problem:
min
w,b
1
2
wTw
subject to yk(w · xk + b) > 1, ∀k (3.13)
Eq. 3.13 is an example of a quadratic programming problem where the aim is to minimize a quadratic
function subject to a set of linear inequality constrains. In order to solve this constrained optimization
problem, Langrange multipliers are introduced:
L(w, b,Λ) =
1
2
wTw −
K∑
k=1
αk[yk(w
Txk + b)− 1] (3.14)
where Λ = (α1,...,αk) is the vector of non-negative Lagrangian multipliers correspondent to the con-
strains in Eq. 3.13. The aim is to find the w and b values which minimize and the α which maximizes
Eq. 3.14. This can be achieved by differentiating L with respect to w and b and setting the derivatives
to 0:
∂L(w, b,Λ)
∂w
= 0 =⇒ w =
K∑
k=1
αkykxk (3.15)
∂L(w, b,Λ)
∂b
= 0 =⇒
K∑
k=1
αkyk = 0 (3.16)
Substituting 3.15 and 3.16 back in 3.14, the dual representation of the problem is obtained:
W (Λ) =
K∑
k=1
αk − 1
2
K∑
k=1
K∑
j=1
ykyjαkαj(x
T
k xj), (3.17)
where the vectors appears only inside of dot products. In order to obtained the solution, Eq. 3.17 is
maximized with regard to α. Finally, the Karush-Kuhn-Trucke condition has to be satisfied according
to optimization theory, which states that αk = 0 is verified for points inside the class and do not
contribute to the solution. On other hand, αn 6= 0 is verified for points that lie on the margin (support
vectors) and do contribute to the solution.
When no linear separation of a dataset is possible, SVM are combined with kernel techniques.
The data is mapped into a higher dimensional space becoming linearly separable and the hyperplane
corresponds to a non-linear decision boundary in the input space. The dual representation of linear
relations previously described, allows the training algorithm to depend on the data only through inner
products between all pairs of observed point without explicitly defining its coordinates. Therefore, if
the kernel function is defined by K(xk, xj) = Φ(xk) ·Φ(xj) then there is no need to know the mapping
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Φ explicitly. The most commonly used kernel is the Gaussian Radial Basis Function (RBF):
K(xk, xj) = e
(−γ‖xk−xj‖2), (3.18)
where γ > 0 defines the width. There are several other kernels, and the choice of the kernel to
use depends on the characteristics of the classification problem, such as the number of features and
samples available. For a high dimensional problem, the linear kernel has been proved to yield better
classification results, although in some cases the RBF kernel is more suitable [63].
All formulations presented so far were made based on the assumption that a linear separation of the
data is possible either on the input space or in the high-dimensional space. For non-separable classes,
the optimization process is modified so that misclassification of the features vectors are allowed. Thus,
slack variables ε are introduced to measure the degree of misclassification and now the optimization
problem involves maximizing the margin and minimizing the error:
min
w,ε,b
{
1
2
wTw + C
K∑
k=1
εk
}
,
subject to yk(w · xk + b) > 1− εk
and εk > 0, ∀k (3.19)
Where the parameter C is a positive constant that controls the trade-off between allowing training
errors and forcing rigid margins. Hence, a soft margin is created which permits some misclassifications.
Increasing the value of C increases the penalty for misclassifying points, forcing the creation of a more
accurate, but less general model. In the present thesis, the SVM classifier was applied using LIBSVM,
a toolbox developed by Chang and Lin [64].
3.4.2 Classifier Performance - Nested Cross-Validation
The performance assessment of the classifier is performed in order to optimize the parameters and
to evaluate the validity of the obtained model. When a large dataset is available, the data is split into
3 disjoint groups, namely, the training set, the validation set and the test set. The training set is used
to train the algorithm and its parameters are chosen according to the best results obtained using the
validation set. Then the classifier predicts the class of the test data. Thus, the performance of the
classifier is estimated by computing the mean accuracy obtained in a sufficiently large test dataset.
It is of utmost importance to ensure that the data used to train the algorithm is not the same data
used to evaluate its performance, since it would yield to an overoptimistic estimative of the error.
However, when the size of the dataset is small, i.e., the number of features broadly exceeds the number
of samples, it is not recommended to leave out data from the learning stage since sufficient samples
are needed to construct the classification model. Cross-validation strategy was designed to overcome
the lack of a sufficiently large dataset. The most commonly used method is the k-fold cross-validation,
where data is randomly partitioned into k subsets. One of the sets is used as validation set and the
remaining k-1 subsets are used for training. This procedure is repeated for different left out portions.
Then, the average error of all iterations is computed and it can be interpreted as the true error of the
classifier.
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In 2006, Varma and Simon [65] demonstrated that using the cross-validation strategy to estimate
the error of a classifier that has itself been tuned using the cross-validation leads to a significantly
biased estimation of the true error. Hence, a nested cross-validation method, schematized in Fig. 3.6,
was proposed.
Figure 3.6: Illustration of the nested cross-validation scheme. This procedure consists in an inner and an
outer loop. Two different classes are represented by green (class 1) and red (class 2) colors. In the outer loop,
the initial dataset is split into k folds (in the example there are 5 folds). In the present schematic representation,
the number of samples of each class is the same in each fold. One of the folds is chosen as test set and it is
left out of the inner loop. The remaining data is again divided into several (k or other number) folds, and one
of the folds is chosen as validation set and the remaining k-1 folds constitute the training data. The tunning
of the parameters is achieved by performing a standard cross-validation procedure. The averaged accuracy
results are computed leading to the identification of the optimal parameters. The model with these parameters
is then used to the classification of the test set, with a model learned from all the data entered in the inner
cycle. This process is repeated k times, each time leaving a different fold out of the inner cycle.
This method consists of an inner and an outer loops. Firstly, in the outer loop, the initial dataset
is partitioned into k folds, usually 5 or 10 folds are used. The partition may be random or take into
account the number of samples of each class in each fold. One of the folds is left out of the inner cycle
and used as test set and the remaining k-1 folds are used as training data entering the inner loop. The
training data is again divided into k or other number of folds. One of the folds is used as validation set
and the remaining folds are used as training data. A standard cross-validation procedure is performed
within this inner loop, and repeated k-times, where in each iteration, different folds are chosen as
validation set. The optimal parameters are chosen according to the mean of the classification accuracy
computed across all iterations. Finally, the model obtained is used to classify the test set. Since the
test set did not enter the inner loop where the parameter optimization took place, this procedures
leads to an unbiased estimation of the classifier performance. In the present thesis, a nested 10-fold
cross-validation strategy was applied.
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The present chapter begins by describing the characteristics of the study population and the neu-
roimaging data analyzed. The imaging pre-processing conducted by ADNI is also described in Section
4.1. The experimental design is explained in Section 4.2 and the results obtained are presented and
discussed in Section 4.3.
4.1 Neuroimaging Data
The neuroimaging data used in the present work were retrieved from the ADNI database. The
primary goal of ADNI is to develop imaging, clinical, genetic and biochemical biomarkers for baseline
characterization and longitudinal analysis of AD. The study began in 2004 and it enrolled, in its first
phase (ADNI1), 400 MCI patients, 200 individuals suffering from AD and 200 elderly control subjects.
About half of these subjects underwent FDG-PET scans at the baseline and, according to the ADNI
protocol, AD patients were also submitted to follow-up scans at month 6, 12 and 24, CN subjects at
6, 12, 24 and 36 and MCI patients at 6, 12, 18, 24 and 36 month. More detailed information on the
ADNI study can be found at http://adni.loni.usc.edu/.
4.1.1 Participants
Since the ADNI protocol did not include scans at month 18 and 36 for all the clinical groups,
only FDG-PET scans at baseline, month 6, 12 and 24 were retrieved for the present study. Table
4.1 summarizes the demographic (number of subjects, mean age and percentage of males) and clinical
information (mean MMSE score at baseline and follow-ups, and the distribution of the CDR scores at
baseline) of the study population. Participants enrollment was also conditioned by the CDR score: 0
for CN, 0.5 for MCI and 0.5 or more for AD patients. To ensure that the classification was only based
on disease-specific imaging information rather than the intrinsic age and gender captured by the scans,
a 2 sample t-test was performed between different clinical groups for age and gender. All the results
(CN vs AD, CN vs MCI, MCI vs AD) of the t-test, for the null hypothesis that the data have equal
means and variances, both for age and gender, yield p-values higher than 0.05, which means that the
null hypothesis can not be rejected. Hence, one can conclude that the differences of age and gender
between clinical groups are not statistically significant.
Group AD MCI CN
Number of subjects 48 109 66
Age (µ ± σ) 76.5 ± 6.7 74.8 ± 7.1 75.9 ± 4.5
Sex (% of Males) 56.3 63.3 62.1
MMSE at baseline (µ ± σ) 23.4 ± 2.0 27.2 ± 1.6 29.1 ± 1.0
MMSE at month 6 (µ ± σ) 22.5 ± 3.2 26.9 ± 2.5 29.1 ± 0.8
MMSE at month 12 (µ ± σ) 21.3 ± 3.9 26.6 ± 2.7 29.1 ± 1.3
MMSE at month 24 (µ ± σ) 20.0 ± 4.9 25.7 ± 3.5 29.0 ± 1.1
CDR = 0 (%) 0 0 100
CDR = 0.5 (%) 35 100 0
CDR = 1 (%) 65 0 0
Table 4.1: Demographic and clinical information of the study population. µ and σ stand for mean and
standard deviation. MMSE - Mini-Mental State Examination; CDR - Clinical Dementia Rating.
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4.1.2 Imaging Pre-Processing
The FDG-PET scans of the ADNI database were acquired according to one of three standardized
protocols [66]: 30-minute static (a single 30-minute frame, 30 to 60 minutes post-injection), 30-minute
dynamic (six 5-minute frames, 30 to 60 minutes after FDG injection) and 60-minute dynamic (60
minutes dynamic protocol composed of 33 frames starting at the moment of the tracer injection). In
order to standardize the PET data acquired with different systems, the ADNI researchers performed
a series of preprocessing steps including [67]: registration of the several scans, acquired during a single
visit, to each other and averaging; reorientation of the averaged image to a common spatial orientation
and resample using a grid having 1.5 mm cubic voxels; filtration of the reoriented and resampled image
with a scanner-specific function to provide images with an apparent resolution similar to the lowest
resolution scanners used in ADNI.
The ADNI preprocessing procedure also includes the intensity normalization of the FDG-PET
images. Therefore, in order to investigate the intensity normalization methods proposed in the present
work, it was necessary to retrieve the non-normalized FDG-PET images from de ADNI database.
However, these images were not aligned, so in order to make voxel-wise comparisons, all images had to
be warped into the MNI152 standard space. Hence, the correspondent 1.5T MRI scans of each subject
at each time-point were also retrieved from ADNI. Similarly to the FDG-PET images, the MR images
had undergone a series of preprocessing steps by ADNI researchers in order to eliminate artifacts.
These included corrections for gradient non-linearity distortions using a scanner-specific function and
corrections for non-uniformities in the image intensity.
The procedure to warp all the images into the MNI152 standard space was achieved by performing
the following steps. Firstly, the brain tissue in all MR images was extracted (skull-stripping) and
segmented into white-matter and gray-matter. The extraction of brain tissue was performed with
FreeSurfer [68] and the tissue classification was conducted with SPM8 [69]. Secondly, all PET images
were co-registered with the corresponding skull-stripped MR images using SPM8. In order to conduct
these co-registrations, rigid-body transformations (6 degrees of freedom) and an objective function
based on the normalized mutual information between the two images were applied [70]. Thirdly, the
MR images acquired for each subject at baseline and follow-up scans were non-linearly registered into
a subject specific template using the DARTEL toolbox from SPM8 [71]. Finally, all the baseline MR
images were non-linearly registered to an inter-subject template using DARTEL, and the resulting
template was mapped to the MNI-ICBM 152 non-linear symmetric atlas (version 2009a) [72] using
an affine transformation. After completing the aforementioned steps, the original PET and MR im-
ages were resampled into the MNI152 standard space with a 1.5×1.5×1.5 mm resolution using the
appropriate composition of transformations. The final images were represented by a 121×145×121
matrix.
4.2 Experimental Design
The main goal of the present work was to evaluate the value of longitudinal information for the
classification of CN, MCI and AD subjects. Additionally, the influence of the intensity normalization
of the FDG-PET images on the performance of the classification task was investigated. The extraction
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of features was performed using a voxel-wise and a multi-region analysis and different filter methods
were applied in order to select the most relevant features. The methods proposed were evaluated
in both cross-sectional and longitudinal data and, in order to assess their performance, classification
experiments were conducted for CN vs AD, CN vs MCI and MCI vs AD. A detailed description of the
experimental design and the implemented methods is now presented.
Intensity Normalization Methods
Three different methods for the intensity normalization of the FDG-PET images were tested, namely,
the CGM, the regional mean and the reference cluster approaches. For the regional mean intensity
normalization, the cerebellum and the brainstem were used (see Chapter 3). Regarding the reference
cluster intensity normalization, the implemented method was based on the approach proposed by
Yakushev et al., [34] (see Chapter 3), but introducing a different process for the selection of the
reference cluster. The original method performs a search within the clusters obtained, and the cluster
containing the voxel with the highest t-value is used as reference cluster. In this work, the mean of the
t-values of each selected cluster is extracted, and the cluster with the highest t-value mean is used as
reference. Hence, a more robust method is introduced, since the choice of the reference cluster is based
on the mean of all the t-values of a certain region rather than just a single t-value. Furthermore, since
the size of the images used in the work of Yakushev et al. [34] (91×109×91) is different from the images
used in present work (121×145×121), the values of the parameters t and r had to be adjusted. A large
value of r implies that larger spatial extent of contiguous voxels is required, and a large value of t means
than only regions with large intensity differences between two groups are selected. Consequently, the
number and area of the clusters selected will be small. On the other hand, if both parameter values
are small, the area of the selected clusters will be large and the reference cluster for normalization will
comprise a larger region. Therefore, it is necessary to find the most suitable combination of r and t
values. Due to the extreme computational cost implied in the optimization of the parameters of the
reference cluster method in each classification task, a grid search was conducted within the training
set in order to estimate de best parameters for each pair of clinical groups, at each time-point data
(Table 4.2).
CN vs AD CN vs MCI MCI vs AD
t r
Ref.
Cluster
t r
Ref.
Cluster
t r
Ref.
Cluster
Baseline 2 343 SMC 1 27 Cerebellum 3 125 SMC
Month 6 3 343 Cerebellum 1 27 Cerebellum 3 125 SMC
Month 12 4 729 SMC 1 27 SMC 3 343 SMC
Month 24 4 1331 SMC 2 27 Brainstem 3 343 Brainstem
Table 4.2: Optimal parameters (t and r) for the reference cluster normalization method and the localization
of the reference cluster. The optimal values were achieved by performing a grid search over t (range: 1 to 5)
and r (range: 33 to 113) using a 10-fold nested cross-validation and performing 10 iterations. The (t,r) pair
with the highest mean cross-validation accuracy was selected.
As one can observe in Table 4.2, the t and r values tend to increase over time, indicating that the
hypermetabolic regions due to the CGM intensity normalization procedure in pathological subjects
compared to controls, increases in terms of intensity and spatial extent. This can be explained by the
fact that the CGM between the different clinical groups tends to diverge along time. Furthermore,
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the parameter values are generally higher for CN vs AD compared to other two pairs, reflecting the
larger CGM differences between these subjects. Regarding the localization of the reference cluster, it
is situated mainly in brain areas referred in literature as conserved regions (see Chapter 3): the SMC,
the cerebellum and the brainstem. The proposed intensity normalization methods were tested using
the best F ∈ [1000:1000:15000] features of the baseline images selected with the t-test.
Feature Extraction
The VI of the FDG-PET images were extracted by using a voxel-based and a multi-region approaches,
for both cross-sectional and longitudinal data. In the voxel-wise analysis, the voxel intensities of the
baseline and follow-up images were obtained and, since the FDG-PET images were represented by a
121×145×121 matrix, a total of 2122945 voxels were available. A mask was applied in order to exclude
all the extracerebral voxels, which contains no information, and a total of 557780 intracerabral voxels
were obtained. Regarding the multi-region analysis, the mean of the voxel intensities was extracted
for each of the 69 regions, at baseline and follow-up scans. For the longitudinal analysis, the VI and
regional differences of each follow-up scans relative to baseline were computed. Therefore, longitudinal
features comprised three different sets, namely: the differences between the baseline and the 6-month
scans, the baseline and 12-month scans and the baseline and the 24-month scans.
Feature Selection Methods
The t-test, linear correlation and mutual information were used to select the most discriminative cross-
sectional and longitudinal features. The performance of the feature selection methods were assessed
using the baseline scans and the differences over a 24-month period. The features were sorted in de-
scending order according to the value obtained in each method (the t-value, the correlation coeficient
and the mutual information). In the voxel-based analysis, the best F ∈ {100, 200, 300, 400, 500, 600,
700, 800, 900, 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, 10000, 11000, 12000, 13000, 14000,
15000, 30000} features were used as input to the classifier. Although the features generated by the
multi-region approach did not suffer from the curse of dimensionality, some of the features might con-
tain no relevant information. Hence, the feature selection methods were also applied to select the best
regional features. The 69 regional features were ranked according to each feature selection method,
and the best F ∈ [1:1:69] features were used for classification.
Cross-sectional and Longitudinal Imaging Data
Firstly, classification experiments were performed using the 6-month, 12-month and 24-month imaging
data and using the VI and regional changes over 6 months, over 12 months and over 24 months. For
the multi-region analysis, all 69 regions were used. For the voxel-based analysis, 1000 features were
selected with t-test in the cross-sectional data. For the longitudinal data, the best 1000 features were
selected in the follow-up scans, and the VI change of the selected voxels were used. Then, the cross-
sectional imaging data were combined with the longitudinal data by simple concatenation of features.
Each single time-point imaging data was combined with the changes between the baseline and the
respective follow-up imaging data. Additionally, the baseline data were also combined with all longitu-
dinal sets. The features were selected in the cross-sectional data with the t-test, and an optimization
of the number of features, with F ∈ [1000:1000:15000] within the training set was performed. For the
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longitudinal data, the best 15000 features were firstly selected with the t-test in the follow-up data.
Then, assuming that voxels with higher differences along the follow-up period correspond to brain
regions with higher atrophy rate due to the progress of the disease, the longitudinal VI differences of
all 15000 features were sorted in descending order. Finally, an optimization of the number of features
with F ∈ [1000:1000:15000] was also performed.
Classification and performance evaluation
In order to evaluate the performance of the methods proposed, the classification was performed with the
SVM classifier for CN vs AD, CN vs MCI and MCI vs AD. For the voxel-based analysis, the number of
features was much larger than the number of instances, thus, a linear kernel was chosen since mapping
the input data into a high-dimensional space using more complex kernels is not necessary. In order to
define the range of the parameter C, the classification was first assessed using a wide range of values.
Fig. 4.1 shows the accuracy obtained when using different values of C parameter, ranging from 2−20
to 220 for CN vs AD, CN vs MCI and MCI vs AD classification. These results were obtained using the
best 1000 VI features selected with t-test in the baseline data with a 10-fold cross-validation strategy,
repeated 10 times. As one can observe in Fig. 4.1, the best accuracy was achieved for C values between
2 and 214 for all three classification tasks. Hence, the C parameter was set to range between 2 and 214
and was tunned in each classification task using a 10-fold nested cross-validation strategy within the
training set.
Figure 4.1: Classification accuracy varying the C parameter of the SVM algorithm for CN vs AD, CN vs
MCI and MCI vs AD classifications. The results were obtained using 1000 VI features selected with the t-test
in the baseline data and adopting a 10-fold nested cross-validation strategy.
For the multi-region analysis, since the number of features is relatively well balanced with the number
of subjects, a RBF kernel was chosen along with the optimization of the C (range: 2 to 214) and γ
(range: 10−5 to 5−2) parameters by performing a grid search adopting a 10-fold nested cross-validation
strategy within the training set. In order to define the range of γ values, a similar procedure to the
one used with the C parameter, was conducted. For all classification tasks and each set of features,
a 10-fold cross-validation strategy was used to assess the classification accuracy, i.e., the dataset was
split, 90% was used for training and 10% was used for testing. This process was repeated 10 times in
order to avoid any bias due to the random partition of the dataset in cross-validation. The comparison
of performance of all proposed classifiers will be based on the average accuracy and standard deviations
obtained. In addition, a 2-sample t-test using a significance level of 0.05, was also performed to assess
the statistical significance of the results obtained with the combination of cross-sectional data and
longitudinal data compared to use the cross-sectional data alone.
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4.3 Results
The results are organized with the following subsections: the intensity normalization methods
(Subsection 4.3.1), features selection methods for both cross-sectional and longitudinal data (Subsec-
tion 4.3.2) and the classification results using the cross-sectional combined with the longitudinal data
(Subsection 4.3.3).
4.3.1 FDG-PET Intensity Normalization Methods
The reference cluster obtained between CN, MCI and AD groups, using the parameters displayed
in Table 4.2 for the baseline data, is presented in Fig. 4.2. Note that the reference clusters were
estimated using the whole sample of subjects for illustration purposes only (in the classification process
the reference cluster was always obtained within the training set).
As one can observe in Fig. 4.2 (a), the reference cluster (areas marked in red) obtained between
CN and AD subjects, is mainly situated in the SMC, although other clusters (areas marked in black)
are also identified in the brainstem and cerebellum. For the CN vs MCI, the reference cluster is in
the cerebellum and brainstem regions, and for MCI vs AD, a small reference cluster is detected in the
SMC.
(a) CN vs AD (b) CN vs MCI (c) MCI vs AD
Figure 4.2: Transaxial section of the brain exhibiting part of the clusters obtained for (a) CN vs AD, (b) CN
vs MCI and (c) MCI vs AD. The reference cluster is marked in red, and the remaining clusters extracted but
not selected are marked in black.
Illustration of the mean of the FDG-PET baseline scans of the whole sample of CN and AD
subjects after intensity normalization to CGM and reference cluster is presented in Fig. 4.3. Areas
of apparent hypermetabolism (marked with a red circle) can be observed in AD subjects compared to
CN subjects when CGM intensity normalization is performed. When the intensity of the FDG-PET
images are normalized to the reference cluster, these artifacts are corrected. Consequently, the overall
reduced metabolism in AD brain compared to CN brain becomes apparent, and the regions that before
exhibited artificial hypermetabolism appear as conserved regions (marked with a green circle).
The classification results using the baseline data normalized to the CGM, regional mean (cerebellum
and brainstem) and reference cluster are shown in Fig. 4.4. As one can observe, the reference cluster
approach achieves higher accuracies compared to the other two methods, in all three classification
tasks. However, the advantages of this method are not so marked for the MCI vs AD classification
task, where the CGM approach reached accuracy values very close to the ones obtained with the
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Figure 4.3: Illustration of the FGD-PET baseline scans (transaxial and coronal sections) of CN and AD
subjects normalized to the GGM (top row) and reference cluster (bottom row). Red circles indicate hyperme-
tabolic areas in AD subjects relative to the CN subjects. Green circles indicates the same regions after the
reference cluster intensity normalization.
reference cluster. This could be due to the fact that for the reference cluster method, one of the
two groups has to be defined as ”normal”. For the MCI vs AD classification, it is assumed that the
MCI group is the control one, which is not accurate since patients diagnosed with MCI have already
begun the neuronal degeneration process. On the other hand, the normalization performed relative
to the brainstem appears to lead to a degradation of the classifier in CN vs MCI and MCI vs AD
classification tasks. Since the reference cluster approach led to superior results, this method was
adopted to normalize the baseline and follow-up imaging data.
4.3.2 Feature Selection Methods
First of all, the features selected by the t-test, linear correlation and mutual information were
visually inspected. To this end, the whole sample of subjects were used and 3000 features were
selected from the baseline scan and another 3000 features were selected from the VI differences along
24 months. No significant differences in the localization of the features selected by the three methods
were detected using both sets of features. Hence, only the result of the t-test analysis is illustrated in
Fig. 4.5, using the baseline data, and in Fig. 4.6, using the longitudinal data.
The selected regions in the baseline scans are mostly located in bilateral temporal lobe, frontal pole,
posterior and anterior divisions of the parahippocampal gyrus and bilateral hippocampus between all
groups. Additionally, the bilateral amygdala was also selected for CN vs AD and MCI vs AD. All
these regions have been reported by several studies (for example, [51], [73], [74]) to be affected in
both MCI and AD conditions. Furthermore, one can observe that higher t-values are obtained for
CN vs AD which is related to higher metabolic differences between CN and AD patients. Lower t-
values are obtained for CN vs MCI which reveals lower brain metabolic differences complicating the
discrimination between CN and MCI subjects.
In the longitudinal data, the t-value is related to differences in metabolic change along time between
groups. For CN vs AD and MCI vs AD, the features selected are very similar to the ones selected at
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(a) CN vs AD (b) CN vs MCI
(c) MCI vs AD
Figure 4.4: Classification results using baseline data normalized relative to the CGM, cerebellum, brainstem
and reference cluster for (a) CN vs AD, (b) CN vs MCI, (c) MCI vs AD. The VI features of the baseline scans
were selected with the t-test.
the baseline. However, for CN vs MCI, the selected features appear to have a more spread distribution
across the brain. Note that during the classification process, the features are selected within the
training set and not with the whole sample of subjects, therefore the features used for classification
may vary, depending on the folds created in the cross-validation procedure.
The classification results using the t-test, the linear correlation and the mutual information as
feature selection methods for the voxel-based analysis are presented in Fig. 4.7 using the baseline
data, and in Fig. 4.8 using the VI change over 24 months.
For both sets of features, similar conclusions can be drawn. As one can observe in Fig. 4.7 and Fig.
4.8, although the mutual information method appears to lead to sightly higher accuracy results when
using a larger number of features, overall, the classifier performance do not seem to benefit much from
the increasing number of selected features. Note also that the minimum number of features used was
100 and the maximum was 300 times superior, and very similar accuracy results were obtained. This
demonstrates the ability of SVM to circumvent the curse of dimensionality. Nevertheless, there are
clear motivations to reduce the dimensionality of the input space, e.g., reduction the computational
cost of the training and test algorithms, elimination of redundant information and selection of the most
relevant features in order to gather more meaningful information from a physiological point of view.
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Figure 4.5: Differences in baseline glucose metabolism between CN, AD and MCI subjects detected with t-
test. Sagital sections (left column), coronal sections (middle column) and transaxial sections (right column) of
the FDG-PET scans are presented. Warmer colors correspond to higher t-values indicating higher metabolism
differences between groups. The highlighted regions correspond to the 30000 selected voxels (voxels with higher
t-values).
Figure 4.6: Differences in glucose metabolism over a 24 months period between CN, AD and MCI subjects
detected with t-test. Sagital sections (left column), coronal sections (middle column) and transaxial sections
(right column) of the FDG-PET scans are presented. Warmer colors correspond to higher t-values that indicate
higher differences in metabolic change along time between groups. The highlighted regions correspond to the
30000 selected voxels (voxels with higher t-values).
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(a) CN vs AD
(b) CN vs MCI
(c) MCI vs AD
Figure 4.7: Comparison of feature selection methods for varying the number of cross-sectional features in the
voxel-based analysis. Mean accuracies and standard deviations are presented.
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(a) CN vs AD
(b) CN vs MCI
(c) MCI vs AD
Figure 4.8: Comparison of feature selection methods for varying the number of longitudinal features in the
voxel-based analysis. Mean accuracies and standard deviations are presented.
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The same classification results, but now for the multi-region analysis, are presented in Fig. 4.9
using the baseline scans, and in Fig. 4.10 using the regional change over 24 months. Similarly to the
voxel-based analysis, none of the feature selection methods led to clearly superior accuracy results,
indicating that the number of regions used did not have a great influence in the classification task.
Comparing the mean accuracies obtained with cross-sectional (Fig. 4.7 and Fig. 4.9) and longi-
tudinal data (Fig. 4.8 and Fig. 4.10), one can conclude that the feature selection algorithms have
better performance when using the cross-sectional data. In particular, for CN vs MCI using the VI
change over 24 months as features, led to very poor classification performance. For this reason, in the
following classification experiments, the features for longitudinal data were selected exclusively in the
follow-up data, as explained in Section 4.2. For all classifications experiments, the CN vs AD clas-
sification achieved consistently the best results, whereas the CN vs MCI classification achieved lower
mean accuracies in all classification tasks. These results were expected since the CMRgl differences
between CN and AD subjects are larger than the differences between CN vs MCI.
Although mutual information appeared to be a more suitable method when a larger number of
features is used, it has the drawback of computational cost. Furthermore, an evidence of accuracy
improvement was not always observed in all the classification experiments when using the mutual in-
formation. Therefore, only the t-test was used as feature selection method in the following classification
experiments.
4.3.3 Cross-Sectional and Longitudinal Classification Data Results
The classification accuracy results using the follow-up scans (6-month, 12-month and 24-month)
and the corresponding differences relative to the baseline, for both voxel-based (using the best 1000
features selected with t-test) and multi-region analysis (using all 69 regions) are displayed in Fig. 4.11.
Similarly to the above observed results (Subsection 4.3.2), for CN vs AD classification (Fig. 4.11
(a)), the longitudinal data has consistently lower classifications results compared to cross-sectional
data, for both analysis. Unlike what was expected, a similar performance for CN vs AD classification
using a voxel-based analysis is observed between all the time-point scans and between the longitudinal
data. Since AD is a progressive disorder, it was excepted that the metabolic differences along time
between CN subjects would be more marked. However, these results may be explained by the fact
that the feature selection was performed independently for each time-point. Hence, only the most
discriminative features are selected in each follow-up imaging data. However, in the multi-region, the
mean accuracy using the longitudinal and cross-sectional data tends to increase for larger temporal
differences for CN vs AD classification. These results reflect the overall metabolic decline along time in
AD patients compared to CN subjects. Since in the multi-region analysis, all 69 regions were used, it is
possible to observe the expected increase in classification performance for larger temporal differences,
unlike the voxel-based analysis for the reasons above mentioned.
For CN vs MCI classification (Fig. 4.11 (b)), the mean accuracy obtained using the cross-sectional
and longitudinal data does not exhibit such obvious differences as in the former plot. In the multi-
region approach, the best cross-sectional results were achieved for the 24-month, as expected. However,
all the longitudinal sets had similar classification performances, reflecting the less marked differences
of metabolic decline along time of CN and MCI subjects. For the voxel-based analysis, similar results
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(a) CN vs AD
(b) CN vs MCI
(c) MCI vs AD
Figure 4.9: Comparison of feature selection methods in the baseline data for varying the number of regional
features. Mean accuracies and standard deviations are presented.
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(a) CN vs AD
(b) CN vs MCI
(c) MCI vs AD
Figure 4.10: Comparison of feature selection methods in the longitudinal data for varying the number of
regional features. Mean accuracies and standard deviations are presented.
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(a) CN vs AD
(b) CN vs MCI
(c) MCI vs AD
Figure 4.11: Classification results using the follow-up data and the follow-up differences relative to the
baseline, using a voxel-based (best 1000 features selected with t-test) and multi-region analysis (all 69 regions).
Mean accuracies and standard deviations are presented.
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were obtained between different cross-sectional data sets and between longitudinal data sets, which
can be explained by the same reasons above mentioned for the CN vs AD classification.
For MCI vs AD (Fig. 4.11 (c)), both cross-sectional and longitudinal data achieved similar ac-
curacies, except for the 24-month that outperformed the other sets of features when using regional
features, similarly to CN vs MCI classification. For the voxel-based approach, there are evident dif-
ferences between cross-sectional and longitudinal data. All the cross-sectional sets led to similar mean
accuracies but classification performance of the cross-sectional data seemed do increase along time.
For the 6-month change, the classification result is very poor, indicating that the metabolic decline
over 6 months is not sufficient to discriminate between MCI and AD subjects even when using the
best 1000 features. For the 12-month and 24-month change the classification results are in line with
the results obtained for the other two classification tasks.
Table 4.3 presents the classification results obtained when combining cross-sectional and longitu-
dinal data, for both voxel-based and multi-region analysis. Additionally, the results using only the
cross-sectional data for all the single time point scans is also presented, in order to facilitate compar-
isons. Since the longitudinal data alone did not perform better than the cross-sectional data (Fig.
4.11), this information was not included in the table.
For the CN vs AD classification, the classification accuracy using the baseline data alone is signifi-
cantly improved when combining the baseline data with the change over 12 months, and the baseline
with change over 24 months, for both voxel-based and multi-region analysis. The best result obtained
was a mean accuracy of 92.6 %, achieved for the combination of the 12-month data and the changes
over 12 months using a voxel-based approach and 87.8 % using a multi-region approach. For the CN vs
MCI classification, using a voxel-wise analysis, the combination of baseline and change over 12 months
led do higher accuracies compared to using the baseline data alone. Moreover, the combination of
month 6 with change over 6 months, and month 12 combined with the change over 12 months led to an
improvement of the classification performances compared to using the cross-sectional data alone. The
best results were achieved for the voxel-based approach, when concatenated the month 12 data with
changes over 12 months (70.2 % against 65.6 % obtained with the multi-region analysis). For the MCI
vs AD classification, using a voxel-based analysis, the combination of the baseline and change over 12
months led to an improvement of the mean accuracy. Moreover, the combination of all the follow-up
data with the respective differences relative to baseline, led to an improvement of the accuracy. The
most remarkable result was obtained for the combination of the month 12 with change over 12 months
that achieved an accuracy of 69.5 %, against 65.7 % when using the cross-sectional data alone.
These results demonstrate that, although the longitudinal information alone did not have much
discriminative power, when it is combined with the cross-sectional data, the classification performance
is improved. However, the incorporation of longitudinal and cross-sectional data, in some particular
cases, did not enhance the results. This can be due to the fact that cross-sectional and longitudinal
features are chosen independently, and it may led to the incorporation of redundant information into
the classifier.
In order to investigate the classifier performance for different number of VI features, the accu-
racy obtained when combining the baseline with change over 12 months was assessed using F ∈
[1000:1000:15000]. The results are displayed in Fig. 4.12 for the CN vs AD, CN vs MCI and MCI
vs AD classification. In addition to the combination of baseline and longitudinal data, the accuracy
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obtained using the baseline data alone is also presented in Fig. 4.12 in order to allow a direct com-
parison. Note that the number of features in each set, for the combination of cross-sectional and
longitudinal data, is twice of the indicated in the axes, since both sets of features are concatenated.
For all three classification experiments, the combination of longitudinal and cross-sectional information
led to higher accuracies when compared to using only baseline data. Furthermore, these differences are
more marked for CN vs AD. This result demonstrates that incorporating the information contained in
longitudinal data, which reflects the larger metabolic decline in AD patients compared to CN subjects,
led to a more successful discrimination between these two groups. The results of the t-test performed
to the differences in the classification results obtained using these two sets of features, for all num-
ber of features, show that these are statistically different (p-value<0.05) for all three classification tasks.
CN vs AD CN vs MCI MCI vs AD
Voxel-wise Multi-region Voxel-wise Multi-region Voxel-wise Multi-region
Baseline 84.2 ± 11.1 81.1 ± 11.1 68.1 ± 10.6 68.5 ± 9.6 71.8 ± 10.3 75.7 ± 8.9
Baseline +
change over 6 months
84.7 ± 10.2 81.2 ± 11.3 63.1 ± 11.2 68.4 ± 10.5 71.3 ± 10.4 72.6 ± 10.1
Baseline +
change over 12 months
91.2 ± 8.0 83.3 ± 9.7 69.3 ± 10.9 68.9 ± 9.5 73.1 ± 10.5 72.3 ± 8.9
Baseline +
change over 24 months
86.4 ± 9.5 87.7 ± 8.9 67.1 ± 9.8 66.9 ± 10.2 68.7 ± 11.0 73.5 ± 10.3
Month 6 86.6 ± 9.8 84.1 ± 10.5 62.0 ± 10.7 65.7 ± 9.5 65.8 ± 10.4 71.2 ± 7.9
Month 6 +
change over 6 months
86.3 ± 9.6 83.5 ± 10.6 63.2 ± 12.4 65.2 ± 9.1 67.7 ± 10.2 71.7 ± 8.0
Month 12 92.8 ± 6.3 87.4 ± 9.8 69.7 ± 10.6 65.1 ± 11.3 65.7 ± 11.5 72.4 ± 10.2
Month 12 +
change over 12 months
92.6 ± 6.7 87.8 ± 9.1 70.2 ± 9.0 65.6 ± 9.6 69.5 ± 11.0 72.7 ± 8.3
Month 24 86.9 ± 10.2 86.6 ± 9.9 66.0 ± 9.2 68.7 ± 8.7 69.1 ± 11.9 77.3 ± 9.0
Month 24 +
change over 24 months
87.1 ± 9.8 87.3 ± 10.1 65.9 ± 8.7 66.7 ± 8.7 70.3 ± 9.7 74.2 ± 9.3
Table 4.3: Classification accuracy (mean ± standard deviation), performing a voxel-based and a multi-region analysis, for
CN vs AD, CN vs MCI and MCI vs AD. The classification accuracy using the cross-sectional data alone (baseline, 6-month,
12-month, and 24-month) is presented, along with the classification accuracy obtained when combining the cross-sectional
and the longitudinal data (change over 6, 12 and 24 months). The best result of each column is highlighted.
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(a) CN vs AD
(b) CN vs MCI
(c) MCI vs AD
Figure 4.12: Classification accuracy as a function of the number of features. The averaged accuracy and the
standard deviation are presented.
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5
Conclusions and Future Work
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The present thesis aimed to investigate the value of longitudinal information for the automatic
classification of AD using 3D FDG-PET images of the brain. The majority of the proposed CAD
schemes for AD are based on the analysis of cross-sectional data. However, since AD is a progressive
neurological disorder, the identification of metabolic decline patterns along time might be useful for
early diagnosis and prediction of the disease course.
In the present work, a simple and intuitive approach was used to extract longitudinal information
from the FDG-PET images. Although the information contained in the changes in metabolic pattern
along time did not appear to have much discriminative power when used by itself, when is was used
in combination with cross-sectional data it was able to enhance the classification performance. In
particular, the combination of the baseline and VI change over 12 months led to significantly better
accuracy results when compared to using only baseline data, for all the classification tasks and using
different number of features. However, the incorporation of longitudinal and cross-sectional data
did not lead to an improvement of the results, in some of the classification experiments. Since the
cross-sectional and longitudinal features are chosen independently, the incorporation of redundant
information into the classifier may occur, which can explain the deterioration of its performance.
Nevertheless, even using simple feature extraction and selection methods, the value of longitudinal
information for automatic diagnosis of AD was demonstrated. Furthermore, the results obtained are
in line with the current state-of-the-art, achieving 91.2 % for CN vs AD, 69.3 % for CN vs MCI and 73.3
% for MCI vs AD, using the baseline data combined with change over 12 months, with a voxel-based
approach. The results obtained in the present thesis suggest that the incorporation of longitudinal
data in CAD systems for AD might provide valuable information for early diagnosis and prediction of
the disease course.
The study of different approaches for intensity normalization of FDG-PET images conducted in the
present work, was driven by the growing body of literature revealing a significant CGM reduction in
AD patients compared to healthy controls. Therefore, global normalization, the most commonly used
method, leads to artificial regional activity overestimating the true levels of CMRgl in AD patients
compared to CN subjects. In the present study, it was proven that this phenomenon influences the
classification task, since the features used are based on the CMRgl represented by the VI of the FDG-
PET images. Among the intensity normalization approaches tested, the reference cluster method led
to the best classification performance for all three classification tasks. On the other hand, the intensity
normalization to cerebellum and brainstem, which have been widely reported in literature as conserved
regions in AD condition, led to relatively poor classification performance, indicating that these regions
may vary across different groups of subjects. Hence, these results suggest that a data-driven method
is the most suitable approach to normalize the FDG-PET images, when comparing healthy controls
and patients with neurological disorders. Moreover, since it is a data-driven method, the definition of
a normalization region a priori is avoided, as well as the segmentation of the brain into ROIs.
Regarding the extraction of features from the FDG-PET images, a voxel-based and a multi-region
analysis were conducted in present work. The voxel-based analysis had consistently better classification
performances than the multi-region analysis for CN vs AD classification. For CN vs MCI classification
task, both analysis led to similar results although, for MCI vs AD discrimination, the multi-region
performed slightly better than the voxel-based approach. Even though it achieved lower accuracies for
MCI vs AD classification, voxel-based analysis may still be a more advantageous option, since the seg-
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mentation of the brain into ROIs is avoided. Furthermore, the pattern of degenerative brain disorders
may not follow standard definitions for anatomical or functional regions, thus, brain segmentation into
ROIs may lead to loss of discriminative information.
In order to overcome the curse of dimensionality emerged with the voxel-based approach, three
feature selection methods were investigated, namely, the t-test, the linear correlation and the mutual
information. For voxel-based analysis, both for cross-sectional and longitudinal data, the mutual
information method performed slightly better in some of the classification tests when using a higher
number of features, compared to two other methods. However, when a small number of features
were used, none of the feature selection methods for the cross-sectional and longitudinal data led to
clearly superior performances. In addition, the advantages of selecting the most discriminative regional
features with these methods were also assessed. For both regional cross-sectional and longitudinal
features, the results obtained did not evidence the benefits of feature selection procedure, and none
of the methods outperformed the others. In the present thesis, the results obtained with mutual
information did not outweigh its computational cost.
Overall, better classification results were obtained using the cross-sectional alone rather than the
longitudinal data alone. However, these differences were less pronounced for CN vs MCI and MCI
vs AD classification. In fact, when regional features were used, the results obtained with both set of
features were very similar for these two classification tasks. These results suggest that the change of
the metabolic pattern along time may provide valuable information for predicting the disease course
in MCI subjects.
Despite these encouraging results, further investigation should be conducted in order to develop
more sophisticated methods for longitudinal feature extraction and selection. Most existing feature
selection methods are designed for a single time-point image and they can not be easily adapted to
select features in multiple time-point images. Moreover, alternative strategies for the combination of
the cross-sectional and longitudinal data more complex than the simple method of concatenation used
in this work, should also be further explored. This procedure should eliminate redundant information
and may improve the classification results when cross-sectional is used in combination with longitudinal
data. In addition, a distinction between MCI converters and MCI non-converts might enhance the
accuracy obtained between CN vs MCI and MCI vs AD classification tasks.
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